Events & Presentations

Recent and future events from Myriad Genetics

Myriad Genetics at 41st Annual J.P. Morgan Healthcare Conference

Paul J. Diaz, president and chief executive officer, Bryan Riggsbee, chief financial officer, and Dale Muzzey, chief scientific officer, presented at the 41st Annual J.P. Morgan (JPM) Healthcare Conference on Monday, Jan. 9, 2023.

  • ASC
  • DSC
  • 01/11/2022

    Myriad Genetics Third Quarter 2022 Financial Earnings

  • 04/08/2022

    Myriad Genetics Second Quarter 2022 Financial Earnings Call

  • 11/05/2022

    BofA Securities 2022 Healthcare Conference

  • 11/01/2022

    Myriad Genetics Third Quarter 2022 Financial Earnings

  • 08/04/2022

    Myriad Genetics Second Quarter 2022 Financial Earnings Call

  • 05/11/2022

    BofA Securities 2022 Healthcare Conference

  • 05/05/2022

    Myriad Genetics First Quarter 2022 Financial Results Conference Call

  • 04/14/2022

    Myriad Genetics Names Mark Verratti Chief Commercial Officer, Dale Muzzey Chief Scientific Officer

  • 04/14/2022

    2022 Annual letter to stakeholders

  • 03/08/2022

    Cowen Health Care Conference

  • 02/24/2022

    Myriad Genetics Fourth Quarter 2021 Financial Results Conference Call

  • 02/18/2022

    SVB Leerink Global Healthcare Conference